A widely used insecticide is drawing renewed scrutiny after UCLA researchers linked long-term exposure to chlorpyrifos with more than 2.5 times the risk of developing Parkinson’s disease. The study goes beyond an epidemiological association, using animal and cell-model experiments to investigate how the chemical may damage the brain. The UCLA findings connect chlorpyrifos exposure to Parkinson’s-related neuronal damage, while also pointing toward a possible way to protect vulnerable cells.
The research combined records from 829 people diagnosed with Parkinson’s and 824 people without the condition. Investigators matched participants’ residential and workplace histories with California pesticide-application data, allowing them to estimate prolonged exposure over time. The work was conducted through UCLA’s long-running Parkinson’s Environment and Genes study, which examines how environmental hazards and inherited susceptibility may combine to influence disease risk. UCLA’s research announcement describes chlorpyrifos as a specific environmental risk factor, rather than treating pesticides as one undifferentiated category.
The human data alone cannot prove that chlorpyrifos directly causes Parkinson’s. To examine whether the association had a biological basis, the team exposed mice to the pesticide in aerosol form for 11 weeks. The animals developed movement problems, lost dopamine-producing neurons and showed two hallmarks associated with Parkinson’s pathology: brain inflammation and abnormal accumulations of alpha-synuclein.
Additional experiments in zebrafish helped researchers trace the damage to autophagy, the cell’s internal recycling and waste-disposal system. When that cleanup pathway was disrupted, defective proteins and other cellular debris accumulated inside neurons. Restoring autophagy or removing excess synuclein protected neurons in the laboratory models, suggesting that therapies aimed at strengthening cellular maintenance could eventually be useful—not only for people exposed to chlorpyrifos, but potentially for other forms of environmentally influenced neurodegeneration.
The findings are especially significant because Parkinson’s biology can begin developing years or decades before recognizable symptoms such as tremor, rigidity and slowed movement appear. The study’s exposure estimates also included agricultural communities in California’s Central Valley, where pesticide use has been an important focus of prior Parkinson’s research. A related UCLA initiative is continuing to examine how pesticides and air pollution may affect neurological health.
Chlorpyrifos remains a contested chemical rather than a simple nationwide-use story. The U.S. Environmental Protection Agency says several states, including California, have prohibited or added restrictions to its use, while California classifies it as a restricted material and toxic air contaminant. The new study does not establish that every person exposed to the insecticide will develop Parkinson’s, and its proposed protective strategy has so far been tested only in laboratory models. The next challenge is determining whether autophagy-targeting treatments can protect human brain cells before irreversible damage occurs.
